Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.
about
The axonal repellent, Slit2, inhibits directional migration of circulating neutrophilsThe C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone lossFood poisoning and Staphylococcus aureus enterotoxinsInteraction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureusSkin microbiota: a source of disease or defence?Evasion of Neutrophil Killing by Staphylococcus aureusBacterial Toxins as Pathogen Weapons Against PhagocytesStaphylococcal manipulation of host immune responsesNeutrophils in innate host defense against Staphylococcus aureus infectionsMacrophage Bactericidal Activities against Staphylococcus aureus Are Enhanced In Vivo by Selenium Supplementation in a Dose-Dependent MannerStaphylococcus aureus secretes a unique class of neutrophil serine protease inhibitorsCharacterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureusStructure of the Tyrosine-sulfated C5a Receptor N Terminus in Complex with Chemotaxis Inhibitory Protein of Staphylococcus aureusStructural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitorA structural basis for Staphylococcal complement subversion: X-ray structure of the complement-binding domain of Staphylococcus aureus protein Sbi in complex with ligand C3dPathogenesis of Staphylococcus aureus abscessesHow do microbes evade neutrophil killing?Comparative prevalence of immune evasion complex genes associated with ß-hemolysin converting bacteriophages in MRSA ST5 isolates from swine, swine facilities, humans with swine contact, and humans with no swine contactMobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSAA shared population of epidemic methicillin-resistant Staphylococcus aureus 15 circulates in humans and companion animals.Pseudomonas evades immune recognition of flagellin in both mammals and plants.Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus.Looking toward basic science for potential drug discovery targets against community-associated MRSAComplement evasion by human pathogens.Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses.Phenol-Soluble Modulin Toxins of Staphylococcus haemolyticusCommunity-associated methicillin-resistant Staphylococcus aureus immune evasion and virulence.Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis.Phenol-soluble modulins--critical determinants of staphylococcal virulence.Epic Immune Battles of History: Neutrophils vs. Staphylococcus aureus.The genetic structure of Staphylococcus aureus populations from the Southwest PacificMolecular pathogenesis of Staphylococcus aureus infectionProduction of an attenuated phenol-soluble modulin variant unique to the MRSA clonal complex 30 increases severity of bloodstream infection.Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice.Functional basis for complement evasion by staphylococcal superantigen-like 7.Capsule-negative Staphylococcus aureus induces chronic experimental mastitis in mice.DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model.Complement-targeted therapeuticsStaphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis.The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages.
P2860
Q24316445-2AFF156D-6D75-47ED-A2B1-DB5313A2B925Q24618908-9D03A6F2-8DC1-4959-8B7E-5C4B389AB118Q24620484-D4C67BC0-57DF-4180-AA63-8ADE7703DEE7Q24646878-36F702A9-76E6-4AA9-B50D-5A7658E6D7B0Q24651518-CBC5A665-603D-40C3-994C-1B2B686B0914Q26752941-114AFFF5-1AA5-4591-B6B3-594EF2ED6C33Q26766446-D567F898-21B8-4268-9D33-D27F9C76EACFQ26798461-0857C8DB-D300-4010-8AF4-05A20B6DD2DAQ27024628-E67E4472-3841-4535-9397-3181A7472BB0Q27300703-972D2328-329D-48A3-8811-7E8E9127235DQ27640538-616F2906-6B13-4A14-AAAD-757CA1B26E05Q27647311-EC05822A-7D04-4FF4-B84D-BA9775EB5CF3Q27653982-0A01F6A2-DAE5-4832-ADE8-7A83291BF044Q27655786-388A8FA5-C0F8-4F98-9975-5862C776035CQ27665619-2E386247-6608-4376-84F4-282EDB195628Q28080781-70010DF2-3D23-480E-89ED-9D36F7199267Q28260721-BFDF7E33-09D3-46DD-82D9-0F82B3558038Q28393625-82AC5732-8CC2-4547-A9DA-5FAB4CCFA1E0Q28475821-7112FF69-FA46-4E91-AC46-550F920C6E5DQ30362524-48957C88-5D73-457B-8ED0-5F4A5DE34CB2Q31030677-50D1D768-5493-44A6-90C7-8922AD9B4976Q33417894-F3A1E74E-28C8-477D-ADC6-B9B242DA9CC4Q33560722-C81D5F6D-535D-4376-9605-D2A8B1231659Q33623972-B4C87709-2C83-4CD0-9D05-2945751569B9Q33709446-97F25481-9B6B-4687-9F29-E8243CAFF87FQ33720427-01C28109-D927-473B-A408-6C73EAA0DDAFQ33781148-28011318-C6CA-489C-9B5C-A3953BB155A8Q33807749-89E5FB0D-5E4D-4AC6-81AC-5F41D92C9B85Q33812717-0E6E44CB-29F1-4361-9578-AC742D4A9C33Q33854487-BCA928E1-813B-4EE5-9C14-D8A7709F6ADFQ33863207-51F238EF-818F-49D0-B585-F442694BF4F3Q34056748-B5FB4B35-D58D-4E87-A136-F075F552C9E0Q34075795-2479C55D-9F99-4489-82F8-9BBF93A3E820Q34096536-FF3F86B5-1182-4E8F-A0CF-D09C04FEABF0Q34137944-31268E04-4AA1-4CBB-83C0-A447E8047B35Q34194538-00EB7110-2D3A-46E9-9362-A0C7EDA5DD5CQ34194581-36F715C2-AE42-484D-9179-24DF5B68C558Q34255011-CE938A12-2AA8-4C0D-9527-1369F7C1DF52Q34291634-22BEA0C6-37A1-4A33-AC7D-54BB1CEAAA42Q34353754-52DB3D47-9F01-4AFE-9411-A71A2CE7408C
P2860
Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Chemotaxis inhibitory protein ...... terial antiinflammatory agent.
@ast
Chemotaxis inhibitory protein ...... terial antiinflammatory agent.
@en
type
label
Chemotaxis inhibitory protein ...... terial antiinflammatory agent.
@ast
Chemotaxis inhibitory protein ...... terial antiinflammatory agent.
@en
prefLabel
Chemotaxis inhibitory protein ...... terial antiinflammatory agent.
@ast
Chemotaxis inhibitory protein ...... terial antiinflammatory agent.
@en
P2093
P2860
P356
P1476
Chemotaxis inhibitory protein ...... cterial antiinflammatory agent
@en
P2093
Andreas Peschel
Carla J C de Haas
Erik C J M Heezius
Floor Weerkamp
Karin Ellen Veldkamp
Kok P M Van Kessel
Miriam J J G Poppelier
Willem J B Van Wamel
P2860
P304
P356
10.1084/JEM.20031636
P407
P577
2004-03-01T00:00:00Z